课题基金 / 基金详情

FACTORS CONTROLLING TOLERANCE TO APOMORPHINE TREATMENT IN PARKINSON'S DISEASE

FACTORS CONTROLLING TOLERANCE TO APOMORPHINE TREATMENT IN PARKINSON'S DISEASE
控制帕金森病阿扑吗啡治疗耐受性的因素
批准号：
3764473
负责人：
STEPHEN T GANCHER
金额：
$0.0万
依托单位：
OREGON HEALTH & SCIENCE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/3764473
关键词：
Parkinson's disease antiparkinson drugs apomorphine drug adverse effect drug screening /evaluation drug tolerance human subject human therapy evaluation neuromuscular disorder chemotherapy pharmacokinetics

项目摘要

项目成果

STEPHEN T GANCHER的其他基金

相关文献

中文摘要
翻译
这些研究的目的是为帕金森症设计更好的治疗方法。 并探讨阿朴吗啡在治疗慢性阻塞性肺疾病中的实用性。 剧烈波动。我们认为在帕金森病患者中 波动，对多巴胺能刺激的敏感性降低 在治疗后几个小时内发生，但这种损失 几个小时后，敏感度就会逆转。
英文摘要
The aim of these studies is to design better therapies for parkinsonism and to investigate the practicality of apomorphine in the treatment of severe fluctuations. We believe that in the parkinsonian patient with fluctuations, a decrease in the sensitivity to dopaminergic stimulation occurs within several hours of treatment, but that this loss of sensitivity is reversed after a several hour period.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SUBLINGUAL APOMORPHINE IN PARKINSON'S DISEASE--TOLERABILITY AND EFFICACY
SUBLINGUAL APOMORPHINE IN PARKINSON'S DISEASE--TOLERABILITY AND EFFICACY
SUBLINGUAL APOMORPHINE IN PARKINSON'S DISEASE--TOLERABILITY AND EFFICACY
ALTERATIONS IN DOPAMINERGIC RESPONSE IN PARKINSONISM